Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-06-11 Option Award | 2024-06-12 8:00 pm | N/A 2034-06-10 | KALA BIO Inc. | KALA | PERRY GREGORY D Director | 4,550 | $0 | 14,044 (Direct) | View |
2024-05-07 Option Award | 2024-05-09 4:30 pm | N/A 2034-01-31 | Merus N.V. | MRUS | PERRY GREGORY D Chief Financial Officer & PFO | 107,300 | $0 | 107,300 (Direct) | View |
2023-06-22 Option Award | 2023-06-23 8:00 pm | N/A 2033-06-21 | Kala Pharmaceuticals Inc. | KALA | PERRY GREGORY D Director | 17,264 | $0 | 19,802 (Direct) | View |
2023-06-14 Option Award | 2023-06-15 4:23 pm | N/A 2033-06-14 | Merus N.V. | MRUS | PERRY GREGORY D Chief Financial Officer | 372,924 | $0 | 372,924 (Direct) | View |
2023-06-08 Option Award | 2023-06-12 4:14 pm | N/A 2033-06-08 | Merus N.V. | MRUS | PERRY GREGORY D Director | 14,414 | $0 | 14,414 (Direct) | View |
2023-05-31 Option Award | 2023-06-02 8:00 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | PERRY GREGORY D Director | 1,738 | $0 | 2,538 (Direct) | View |
2023-05-31 Disposition | 2023-06-02 8:00 pm | N/A 2028-02-28 | Kala Pharmaceuticals Inc. | KALA | PERRY GREGORY D Director | 1,738 | $0 | 2,538 (Direct) | View |
2022-06-16 Option Award | 2022-06-17 4:45 pm | N/A 2032-06-15 | Kala Pharmaceuticals Inc. | KALA | PERRY GREGORY D Director | 40,000 | $0 | 40,000 (Direct) | View |
2022-05-31 Option Award | 2022-06-02 4:05 pm | N/A 2032-05-31 | Merus N.V. | MRUS | PERRY GREGORY D Director | 16,604 | $0 | 16,604 (Direct) | View |
2022-02-25 Option Award | 2022-02-28 6:50 pm | N/A 2032-02-24 | Finch Therapeutics Group Inc. | FNCH | PERRY GREGORY D Chief Financial Officer | 80,000 | $0 | 80,000 (Direct) | View |
2021-06-17 Option Award | 2021-06-21 5:30 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | PERRY GREGORY D Director | 20,000 | $0 | 40,000 (Direct) | View |
2021-05-28 Option Award | 2021-06-02 4:10 pm | N/A 2031-05-28 | Merus N.V. | MRUS | PERRY GREGORY D Director | 6,120 | $0 | 6,120 (Direct) | View |
2021-03-18 Option Award | 2021-03-18 9:30 pm | N/A 2031-03-17 | Finch Therapeutics Group Inc. | FNCH | PERRY GREGORY D Chief Financial Officer | 55,386 | $0 | 55,386 (Direct) | View |
Ownership | 2021-03-18 9:19 pm | N/A 2028-05-06 | Finch Therapeutics Group Inc. | FNCH | PERRY GREGORY D Chief Financial Officer | 0 | $0 | 304,254 (Direct) | View |
2020-06-30 Option Award | 2020-07-02 4:00 pm | N/A 2030-06-30 | Merus N.V. | MRUS | PERRY GREGORY D Director | 8,631 | $0 | 8,631 (Direct) | View |
2020-06-25 Option Award | 2020-06-29 9:55 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | PERRY GREGORY D Director | 20,000 | $0 | 20,000 (Direct) | View |
Ownership | 2020-01-02 09:00 am | N/A 2026-05-18 | Merus N.V. | MRUS | PERRY GREGORY D Director | 0 | $0 | 36,133 (Direct) | View |